Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis
Public ClinicalTrials.gov record NCT00373516. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Study of the Safety and Efficacy of Two Dosing Regimens of QRX-101 (Becocalcidiol) Ointment in the Treatment of Plaque-Type Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of two dosing regimens of QRX-101 ointment (75 mcg/g QD and 75mcg/g BID) in the treatment of plaque-type psoriasis when applied topically twice daily for 8 weeks
Study identification
- NCT ID
- NCT00373516
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Interventions
- Vehicle (Placebo) applied BID Drug
- QRX-101 75 mcg/g ointment applied QD Drug
- QRX-101 75 mcg/g ointment applied BID Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Mar 2005 (Type not available)
- Last update posted
- Sep 8, 2006
2004 – 2005
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Site | Hot Springs | Arkansas | 71913 | — |
| Clinical Research Site | Santa Rosa | California | 95404 | — |
| Clinical Research Site | Overland Park | Kansas | 66215 | — |
| Clinical Research Site | Lexington | Kentucky | 40509 | — |
| Clinical Research Site | Louisville | Kentucky | 40217 | — |
| Clinical Research Site | Ann Arbor | Michigan | 48109 | — |
| Clinical Research Site | Edina | Minnesota | 55435 | — |
| Clinical Research Site | Winston-Salem | North Carolina | 27157 | — |
| Clinical Research Site | Temple | Pennsylvania | 19560 | — |
| Clinical Research Site | Anderson | South Carolina | 29621 | — |
| Clinical Research Site | Simpsonville | South Carolina | 29681 | — |
| Clinical Research Site | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00373516, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 8, 2006 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00373516 live on ClinicalTrials.gov.